Combining anti-inflammatory drug with the morning after pill boosts effectiveness, study finds
BMJ 2023; 382 doi: https://doi.org/10.1136/bmj.p1920 (Published 18 August 2023) Cite this as: BMJ 2023;382:p1920- Janice Hopkins Tanne
- New York
A combination of levonorgestrel—known as “plan B” or the “morning after pill”—and the anti-inflammatory drug piroxicam is more effective in preventing pregnancy compared with levonorgestrel alone, according to a randomised controlled trial.1
The study involved 860 women who sought emergency contraception within 72 hours of unprotected intercourse at a major community sexual and reproductive health service in Hong Kong between 2018 and 2022. The results, published in the Lancet, showed that the combination regimen prevented 94.7% of expected pregnancies, compared with 63.4% with levonorgestrel alone.
Lead author Raymond Li, clinical associate professor at the University of Hong Kong’s department of obstetrics and gynaecology, said, “Our study is the first to suggest that a readily available and safe drug taken at the same time as the levonorgestrel pill can prevent more pregnancies than levonorgestrel alone. We hope these results will lead to …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.